Unilever buys Grüns supplements

Unilever is making a decisive pivot: scaling its Beauty & Wellbeing division at speed while freezing hiring and carving out its massive foods business. At the center of this strategy is the bold acquisition of Grüns, a US greens supplement brand that has rocketed to shipping 10 million gummies a day and a $500 million valuation in under two years. This is more than a bet on vitamins—it’s a bid to cement leadership in high-growth, premium wellness categories, even as regulators eye supplement claims and digital marketing costs soar.

But here’s the catch: the new playbook relies on ramping up influencer-driven marketing and AI-generated content instead of growing headcount. Half of Unilever’s ad budget is now funneled into social, and the company has partnered with 300,000 creators to rapidly push products—yet that scale brings tough questions about measurement, brand safety, and whether customer acquisition costs can be kept in check. Meanwhile, the $15.7 billion Reverse Morris Trust deal with McCormick aims to streamline food operations, but leaves big questions in markets like Nigeria, where the fate of local brands and jobs is uncertain and regulatory hurdles could drag the process out to 2027.

Featuring insights from The Guardian Nigeria, this episode unpacks how Unilever’s “scale without headcount” strategy could shape not just its balance sheet, but how global brands are built and marketed in the years ahead.

Powered by Apisod.com